期刊文献+

The complex roles of m^(6)A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseases

在线阅读 下载PDF
导出
摘要 N6-methyladenosine(m^(6)A), the most prevalent and conserved RNA modification in eukaryotic cells, profoundly influences virtually all aspects of mRNA metabolism. mRNA plays crucial roles in neural stem cell genesis and neural regeneration, where it is highly concentrated and actively involved in these processes. Changes in m^(6)A modification levels and the expression levels of related enzymatic proteins can lead to neurological dysfunction and contribute to the development of neurological diseases. Furthermore, the proliferation and differentiation of neural stem cells, as well as nerve regeneration, are intimately linked to memory function and neurodegenerative diseases. This paper presents a comprehensive review of the roles of m^(6)A in neural stem cell proliferation, differentiation, and self-renewal, as well as its implications in memory and neurodegenerative diseases. m^(6)A has demonstrated divergent effects on the proliferation and differentiation of neural stem cells. These observed contradictions may arise from the time-specific nature of m^(6)A and its differential impact on neural stem cells across various stages of development. Similarly, the diverse effects of m^(6)A on distinct types of memory could be attributed to the involvement of specific brain regions in memory formation and recall. Inconsistencies in m^(6)A levels across different models of neurodegenerative disease, particularly Alzheimer's disease and Parkinson's disease, suggest that these disparities are linked to variations in the affected brain regions. Notably, the opposing changes in m^(6)A levels observed in Parkinson's disease models exposed to manganese compared to normal Parkinson's disease models further underscore the complexity of m^(6)A's role in neurodegenerative processes. The roles of m^(6)A in neural stem cell proliferation, differentiation, and self-renewal, and its implications in memory and neurodegenerative diseases, appear contradictory. These inconsistencies may be attributed to the timespecific nature of m^(6)A and its varying effects on distinct brain regions and in different environments.
出处 《Neural Regeneration Research》 SCIE CAS 2025年第6期1582-1598,共17页 中国神经再生研究(英文版)
基金 supported by the Natural Science Foundation of Heilongjiang Province of China,Outstanding Youth Foundation,No.YQ2022H003 (to DW)。
  • 相关文献

参考文献14

二级参考文献103

  • 1Jason TC TZEN,Tzyy-rong JINN,Yi-ching CHEN,Feng-yin LI,Fu-chou CHENG,Li-shian SHI,Hank KH SHE,Balance CM CHEN,Vic HSIEH,Mu-lin TU.Magnesium lithospermate B possesses inhibitory activity on Na^+,K^+-ATPase and neuroprotective effects against ischemic stroke[J].Acta Pharmacologica Sinica,2007,28(5):609-615. 被引量:27
  • 2Davie CA. A review of Parkinson’s disease. Br Med Bull 2008; 86:109-127 [PMID: 18398010 DOI: 10.1093/bmb/ldn013].
  • 3Dauer W, Przedborski S. Parkinson’s disease: mechanisms andmodels. Neuron 2003; 39: 889-909 [PMID: 12971891 DOI:10.1016/S0896-6273(03)00568-3].
  • 4Cheon SM, Chan L, Chan DK, Kim JW. Genetics of Parkinson’sdisease - a clinical perspective. J Mov Disord 2012; 5: 33-41 [PMID:24868412 DOI: 10.14802/jmd.12009].
  • 5Lesage S, Brice A. Parkinson’s disease: from monogenic forms togenetic susceptibility factors. Hum Mol Genet 2009; 18: R48-R59[PMID: 19297401 DOI: 10.1093/hmg/ddp012].
  • 6Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinicaldiagnosis of Lewy body Parkinson’s disease. Neurology 2001; 57:1497-1499 [PMID: 11673599 DOI: 10.1212/WNL.57.8.1497].
  • 7Lang AE, Lozano AM. Parkinson’s disease. First of two parts. NEngl J Med 1998; 339: 1044-1053 [PMID: 9761807 DOI: 10.1056/NEJM199810083391506].
  • 8Lang AE, Lozano AM. Parkinson’s disease. Second of two parts. NEngl J Med 1998; 339: 1130-1143 [PMID: 9770561 DOI: 10.1056/NEJM199810153391607].
  • 9Jankovic J. Parkinson’s disease: clinical features and diagnosis. JNeurol Neurosurg Psychiatry 2008; 79: 368-376 [PMID: 18344392DOI: 10.1136/jnnp.2007.131045].
  • 10Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, JonesE. Alzheimer’s disease. Lancet 2011; 377: 1019-1031 [PMID:21371747 DOI: 10.1016/S0140-6736(10)61349-9].

共引文献205

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部